Patents by Inventor Frederick Woolf Goldberg

Frederick Woolf Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110251173
    Abstract: DGAT-1 inhibitor compounds of formula (I), pharmaceutically-acceptable salts and pro-drugs thereof are described, together with pharmaceutical compositions, processes for making them and their use in treating, for example, diabetes and obesity wherein, R1, R2, R3, R4, X2, q, Y1, Y2, n, Q and Z are as defined in the description.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 13, 2011
    Applicant: AstraZeneca AB
    Inventors: Alan Martin BIRCH, Frederick Woolf GOLDBERG, Andrew LEACH
  • Publication number: 20110092526
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.
    Type: Application
    Filed: October 19, 2010
    Publication date: April 21, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Stuart Norman Lile Bennett, Frederick Woolf Goldberg, Andrew Leach, Paul Robert Owen Whittamore, Pernilla Sörme
  • Publication number: 20090048269
    Abstract: The invention relates to chemical compounds of the formula (I), or pharmaceutically acceptable salts thereof, which possess ALK5 (TGF?R1) inhibitory activity and are accordingly useful for their anti-cancer activity and thus in methods of treatment of the human or animal body. The invention also relates to processes for the manufacture of said chemical compounds, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an anti-cancer effect in a warm-blooded animal such as man.
    Type: Application
    Filed: August 12, 2008
    Publication date: February 19, 2009
    Applicant: AstraZeneca AB
    Inventors: Maurice Raymond Finlay, Frederick Woolf Goldberg, Craig Anthony Roberts, Nicola Jane Roberts, David Alan Rudge